Cheryl Nickerson‐Nutter

4.2k citations

44 papers · 3.2k indexed · h-index 28

Impact in

Immunology top 1%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Dermatology top 1%
- Dermatology and Skin Diseases

Papers in

Immunology and Allergy 7
- Cell Adhesion Molecules Research 7
Immunology 23
- T-cell and B-cell Immunology 10
- Psoriasis: Treatment and Pathogenesis 7
- Immune Cell Function and Interaction 6

Co-authors: Mary Collins Martin Hegen Deborah Young Hak‐Ling Ma James C. Keith Lee Napierata Lynette A. Fouser Mayra Senices
Journals: Journal of Clinical Investigation (5 papers)The Journal of Immunology (5 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Cheryl Nickerson‐Nutter

44 papers receiving 3.1k citations

Peers

Countries citing papers authored by Cheryl Nickerson‐Nutter

Since Specialization

Citations

This map shows the geographic impact of Cheryl Nickerson‐Nutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Nickerson‐Nutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Nickerson‐Nutter more than expected).

Fields of papers citing papers by Cheryl Nickerson‐Nutter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Nickerson‐Nutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Nickerson‐Nutter. The network helps show where Cheryl Nickerson‐Nutter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cheryl Nickerson‐Nutter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheryl Nickerson‐Nutter Line = papers co-authored together Cheryl Nickerson‐Nutter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models Science Translational Medicine ·Suraj U. Hettiarachchi, Robrecht Boudens, Jyoti Roy, Fenghua Zhang, Estela Puchulu‐Campanella, Anna Szponar‐Żurowska, Madduri Srinivasarao, Konstantin Tsoyi, Xiaoliang Liang, Ehab Ayaub, Cheryl Nickerson‐Nutter, Iván O. Rosas, Philip S. Low	2020	69
2	In vivo imaging implicates CCR2+ monocytes as regulators of neutrophil recruitment during arthritis Cellular Immunology ·Baomei Wang, Bernd H. Zinselmeyer, Herbert A. Runnels, Timothy P. LaBranche, Phillip A. Morton, Daniel Kreisel, Matthias Mack, Cheryl Nickerson‐Nutter, Paul M. Allen, Mark J. Miller	2012	27
3	Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis Journal of Investigative Dermatology ·Yijun Carrier, Hak‐Ling Ma, Hilda E. Ramón, Lee Napierata, Clayton Small, Margot O’Toole, Deborah Young, Lynette A. Fouser, Cheryl Nickerson‐Nutter, Mary Collins, Kyri Dunussi‐Joannopoulos, Quintus G. Medley	2011	350
4	Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys Lara D. Veeken ·Cheryl Nickerson‐Nutter, Lioudmila Tchistiakova, Nilufer P. Seth, Marion T. Kasaian, 智雄井上, Stéphane Olland, Richard Zollner, William Brady, K M Mohler, Peter Baum, Alan F. Wahl, Donna L. Herber, Yulia Vugmeyster, Susagna Argemí, Neil M. Wolfman, Davinder Gill, Mary Collins, Kyriaki Dunussi‐Joannopoulos	2011	6
5	Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation Arthritis & Rheumatism ·Renoud J. Marijnissen, Marije I. Koenders, Ruben L. Smeets, Mark H. T. Stappers, Cheryl Nickerson‐Nutter, Leo A. B. Joosten, Annemieke M. H. Boots, Wim B. van den Berg	2011	55
6	Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis Bioorganic & Medicinal Chemistry Letters ·Kyung‐Hee Kim, Andreas Maderna, Mark E. Schnute, Martin Hegen, Joób-Fancsaly Árpád, Joy Miyashiro, Laura Lin, Xiaogang Wang, Sean Keegan, 龍銘蔡, M. Schäuble, Cheryl Nickerson‐Nutter, Arthur J. Wittwer, Holly H. Soutter, Nicole Caspers, Seungil Han, Ravi G. Kurumbail, Kyri Dunussi‐Joannopoulos, John Douhan, Allan Wissner	2011	48
7	The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid Neuropharmacology ·Cheryl Nickerson‐Nutter, Debra G. Goodwin, Marina W. H. Shen, Fithriyah Shalihah, Weili Duan, Tarek A. Samad, John C. McKew, Katherine L. Lee, Margaret M. Zaleska, Névéna Mollova, James D. Clark	2010	5
8	Tumor necrosis factor α blockade exacerbates murine psoriasis‐like disease by enhancing Th17 function and decreasing expansion of Treg cells Arthritis & Rheumatism ·Hak‐Ling Ma, Lee Napierata, Nancy Stedman, Stephen Benoit, Mary Collins, Cheryl Nickerson‐Nutter, Deborah Young	2010	99
9	IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammation Journal of Clinical Investigation ·Hak‐Ling Ma, Spencer C. Liang, Jing Li, Lee Napierata, Tom Brown, Stephen Benoit, Mayra Senices, Davinder Gill, Kyriaki Dunussi‐Joannopoulos, Mary Collins, Cheryl Nickerson‐Nutter, Lynette A. Fouser, Deborah Young	2008	461
10	Blockade of the interleukin‐21/interleukin‐21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis Arthritis & Rheumatism ·Deborah Young, Martin Hegen, F. Osmond-Clarke, Matthew J. Whitters, Leo Albert, Leslie Lowe, Mayra Senices, Paul W. Wu, A. I. Kunin, Stefan Brach, Tom Brown, Cheryl Nickerson‐Nutter, James C. Keith, Mary Collins	2007	238
11	Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles Bioorganic & Medicinal Chemistry ·Neelu Kaila, Neal Green, Huan‐Qiu Li, Yonghan Hu, Kristin Janz, Lori K. Gavrin, Jennifer R. Thomason, Steve Tam, Dennis Powell, John W. Cuozzo, J. Perry Hall, Jean‐Baptiste Telliez, Sang Hsu, Cheryl Nickerson‐Nutter, Qin Wang, Lih‐Ling Lin	2007	23
12	Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy Bioorganic & Medicinal Chemistry ·Katherine L. Lee, Mark L. Behnke, Megan A. Foley, Lih-Ren Chen, Weiheng Wang, D Sun, Jill Nunez, Steve Tam, Névéna Mollova, Xin Xu, Marina W. H. Shen, Manjunath Ramarao, Debra G. Goodwin, Cheryl Nickerson‐Nutter, William M. Abraham, Cara Williams, James D. Clark, John C. McKew	2007	26
13	Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis Bioorganic & Medicinal Chemistry Letters ·Yonghan Hu, Neal Green, Lori K. Gavrin, Kristin Janz, Neelu Kaila, Huan‐Qiu Li, Jennifer R. Thomason, John W. Cuozzo, J. Perry Hall, Sang Hsu, Cheryl Nickerson‐Nutter, Jean‐Baptiste Telliez, Lih‐Ling Lin, Steve Tam	2006	54
14	Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin α4β1 with Improved Pharmaceutical Properties Journal of Pharmacology and Experimental Therapeutics ·R. Blake Pepinsky, Leonard Ng’eno, Mark Cornebise, Alan Gill, Kathleen Wortham, Émilie de Fautereau Vassel, Diane R. Leone, Keith Giza, Brian Dolinski, Stuart J. Perper, Cheryl Nickerson‐Nutter, Doreen LePage, Abhijit Chakraborty, Eric T. Whalley, Russell C. Petter, S P Adams, Roy R. Lobb, Daniel M. Scott	2005	17
15	mTOR — beyond transplantation Current Opinion in Pharmacology ·Deborah Young, Cheryl Nickerson‐Nutter	2005	33
16	Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3 S)thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-α-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid Arthritis Journal of Pharmacology and Experimental Therapeutics ·Yuhua Zhang, Jun Xu, Jeremy I. Levin, Martin Hegen, Guangde Li, Heidi Robertshaw, Fionula M. Brennan, Terri Cummons, В. Ивасечко, Nichole R. Vansell, Cheryl Nickerson‐Nutter, D. Barone, K M Mohler, Roy A. Black, J.S. Skotnicki, Jay Gibbons, Marc Feldmann, Philip Frost, G R Larsen, Lih‐Ling Lin	2004	74
17	Characterization of (2R, 3S)-2-({[4-(2-butynyloxy)phenyl]sulfonyl}amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-α converting enzyme International Immunopharmacology ·Yuhua Zhang, Martin Hegen, Jun Xu, James C. Keith, Guixian Jin, Xuemei Du, Terri Cummons, Barbara J. Sheppard, Linhong Sun, Nancy Blanco Neira, Vikram Rao, Qin Wang, Weixin Xu, Rebecca Cowling, Cheryl Nickerson‐Nutter, Jay Gibbons, J.S. Skotnicki, Lih‐Ling Lin, Jeremy I. Levin	2004	48
18	A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT Journal of Clinical Investigation ·Jennifer L. Gommerman, Keith Giza, Stuart J. Perper, Irene Sizing, Apinya Ngam-ek, Cheryl Nickerson‐Nutter, Jeffrey L. Browning	2003	51
19	An Assessment of the Mechanistic Differences Between Two Integrin α4β1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis Journal of Pharmacology and Experimental Therapeutics ·Diane R. Leone, Keith Giza, Alan Gill, Brian Dolinski, Hermann Mettler, Stuart J. Perper, Daniel M. Scott, Leonard Ng’eno, Mark Cornebise, Kathleen Wortham, Cheryl Nickerson‐Nutter, Émilie de Fautereau Vassel, Doreen LePage, Dragas N. Dragas, Eric T. Whalley, Russell C. Petter, S P Adams, Roy R. Lobb, R. Blake Pepinsky	2003	48
20	Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis Journal of Clinical Investigation ·Antonin R. de Fougerolles, Andrew Sprague, Cheryl Nickerson‐Nutter, G Chi-Rosso, Paul D. Rennert, Humphrey Gardner, Philip J. Gotwals, Roy R. Lobb, Victor Koteliansky	2000	188

About Cheryl Nickerson‐Nutter

Cheryl Nickerson‐Nutter is a scholar working on Immunology and Allergy, Immunology, Physiology, Oncology and Dermatology, having authored 44 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (11 papers), T-cell and B-cell Immunology (10 papers), Psoriasis: Treatment and Pathogenesis (7 papers), Cell Adhesion Molecules Research (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Immune Cell Function and Interaction (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Dermatology and Skin Diseases (5 papers). The work is most often cited by research in Immunology (1.8k citations), Dermatology (455 citations), Immunology and Allergy (280 citations), Rheumatology (451 citations) and Hematology (246 citations). Cheryl Nickerson‐Nutter has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Mary Collins, Martin Hegen, Deborah Young, Hak‐Ling Ma, James C. Keith, Lee Napierata, Lynette A. Fouser, Mayra Senices, Tom Brown and Stephen Benoit. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology, Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact